Announcements Trials
Browse Landscape

Phase

Phase 3 14Phase 2 13Phase NA 6Phase 1 3Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Vitamin E × Clear all
NCT00096356 2021-09-29

CoQ10

Wake Forest University Health Sciences

Phase 1 Completed
236 enrolled 11 charts
Breast

Breast Neoplasms, Fatigue

NCT00905918 2014-09-30

Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer

Rutgers, The State University of New Jersey

Phase 1 Completed
14 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00895115 2012-06-14

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Rutgers, The State University of New Jersey

Phase 1 Completed
65 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡